<SEC-DOCUMENT>0001396814-21-000048.txt : 20210803
<SEC-HEADER>0001396814-21-000048.hdr.sgml : 20210803
<ACCEPTANCE-DATETIME>20210803080229
ACCESSION NUMBER:		0001396814-21-000048
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210803
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210803
DATE AS OF CHANGE:		20210803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pacira BioSciences, Inc.
		CENTRAL INDEX KEY:			0001396814
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				510619477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35060
		FILM NUMBER:		211138041

	BUSINESS ADDRESS:	
		STREET 1:		5 SYLVAN WAY
		STREET 2:		SUITE 300
		CITY:			PARSIPPANY
		STATE:			NJ
		ZIP:			07054
		BUSINESS PHONE:		973-254-3560

	MAIL ADDRESS:	
		STREET 1:		5 SYLVAN WAY
		STREET 2:		SUITE 300
		CITY:			PARSIPPANY
		STATE:			NJ
		ZIP:			07054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacira Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20101029

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIRA INC
		DATE OF NAME CHANGE:	20080318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Acquisition Corp
		DATE OF NAME CHANGE:	20070418
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pcrx-20210803.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d6d72ee6-cbe1-4374-abb5-192e775bc754,g:2a856f1f-421d-44b5-bcda-7c20170882e4,d:2819283effd545c39716b64e8d4a2318--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pcrx-20210803</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt:datemonthdayyear" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF80L2ZyYWc6YzE0MjRmMjhhYjdiNGNjYWExOTk1YTk5N2Y1MmU5MDMvdGFibGU6ZWJiNzVhZjJmN2Y5NDA4MGFiZWNiNTIyN2VmNGI4MWYvdGFibGVyYW5nZTplYmI3NWFmMmY3Zjk0MDgwYWJlY2I1MjI3ZWY0YjgxZl8xLTEtMS0xLTA_d1b6273d-63d4-4923-af5e-943691beae87">8/3/2021</ix:nonNumeric><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF80L2ZyYWc6YzE0MjRmMjhhYjdiNGNjYWExOTk1YTk5N2Y1MmU5MDMvdGFibGU6ZWJiNzVhZjJmN2Y5NDA4MGFiZWNiNTIyN2VmNGI4MWYvdGFibGVyYW5nZTplYmI3NWFmMmY3Zjk0MDgwYWJlY2I1MjI3ZWY0YjgxZl8yLTEtMS0xLTA_b861c65c-c656-4122-9fbb-85df77b7d293">0001396814</ix:nonNumeric><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF80L2ZyYWc6YzE0MjRmMjhhYjdiNGNjYWExOTk1YTk5N2Y1MmU5MDMvdGFibGU6ZWJiNzVhZjJmN2Y5NDA4MGFiZWNiNTIyN2VmNGI4MWYvdGFibGVyYW5nZTplYmI3NWFmMmY3Zjk0MDgwYWJlY2I1MjI3ZWY0YjgxZl8zLTEtMS0xLTA_fdbc3baf-21a8-42d4-a2b5-ecc9f35f1ce0">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pcrx-20210803.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-03</xbrli:startDate><xbrli:endDate>2021-08-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2819283effd545c39716b64e8d4a2318_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ5_6127fe69-b8e2-4844-815c-61c49e1bdf27">8-K</ix:nonNumeric></span></div><div style="margin-top:11pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">CURRENT REPORT</span></div><div style="padding-left:33.75pt;padding-right:33.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">Pursuant to Section 13 or 15(d) of the</span></div><div style="padding-left:33.75pt;padding-right:33.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">Securities Exchange Act of 1934</span></div><div style="margin-top:11pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8yMjY_e7701b51-2bbc-44f1-b5be-89a6adcce104">August&#160;3, 2021</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQz_f3480471-04dd-40ff-8ccd-44de7488c768">PACIRA BIOSCIENCES, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:27.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6NTU3ZmQ3OWMzOTVmNDgwOTg3YjlhMTIzYTQ1MzkxYTgvdGFibGVyYW5nZTo1NTdmZDc5YzM5NWY0ODA5ODdiOWExMjNhNDUzOTFhOF8wLTAtMS0xLTA_f169059c-af58-491b-9e03-56f6ca3b0009">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6NTU3ZmQ3OWMzOTVmNDgwOTg3YjlhMTIzYTQ1MzkxYTgvdGFibGVyYW5nZTo1NTdmZDc5YzM5NWY0ODA5ODdiOWExMjNhNDUzOTFhOF8wLTItMS0xLTA_e8e466c4-ae1f-4ac7-9832-b131d273e8eb">001-35060</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6NTU3ZmQ3OWMzOTVmNDgwOTg3YjlhMTIzYTQ1MzkxYTgvdGFibGVyYW5nZTo1NTdmZDc5YzM5NWY0ODA5ODdiOWExMjNhNDUzOTFhOF8wLTQtMS0xLTA_b1f347b7-9058-4a55-a493-781b6d1846ba">51-0619477</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">(State or other jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">(IRS Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUw_572a497d-cff7-4f46-8dc1-cb73bc152117">5 Sylvan Way, Suite 300</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ0_b1a5536e-f3d5-456d-a120-612cf682eb8f">Parsippany</ix:nonNumeric>, <ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUx_cdca1949-132f-429f-9983-eb0a0c53fcd5">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ1_116a1fc8-b8eb-4c0a-920c-a96fd8b5687d">07054</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Address and Zip Code of Principal Executive Offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%">(<ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ2_d7f891da-8577-4bde-bfe0-6da353c4333a">973</ix:nonNumeric>) <ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ3_80e55a02-96ca-42df-971d-433f8237628a">254-3560</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Registrant&#8217;s Telephone Number,&#160;Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:113%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUy_c4325644-8b99-4aec-af29-50f6053aef05">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:113%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ4_069fe899-f4af-41e7-9ade-e638f635d544">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:113%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUz_ff302727-e311-4dec-95b3-cd64b59cf5b0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:113%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjU0_c0aedf38-da1a-4033-a6d6-01f2a654e5c9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6MzNmNzA2Njg0MDk5NGEzM2I5NWI5OTg0NThiMzY3MTcvdGFibGVyYW5nZTozM2Y3MDY2ODQwOTk0YTMzYjk1Yjk5ODQ1OGIzNjcxN18xLTAtMS0xLTA_366fe75b-3f8b-47d2-8c0d-8fb729cd4997">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6MzNmNzA2Njg0MDk5NGEzM2I5NWI5OTg0NThiMzY3MTcvdGFibGVyYW5nZTozM2Y3MDY2ODQwOTk0YTMzYjk1Yjk5ODQ1OGIzNjcxN18xLTItMS0xLTA_f4784542-4378-4015-a78a-2e0098b94ba1">PCRX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6MzNmNzA2Njg0MDk5NGEzM2I5NWI5OTg0NThiMzY3MTcvdGFibGVyYW5nZTozM2Y3MDY2ODQwOTk0YTMzYjk1Yjk5ODQ1OGIzNjcxN18xLTQtMS0xLTA_3bc69477-7782-439a-8c06-6ebd951427bf">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjU1_a01f5c6c-7310-4d32-ad86-783c0bdf4bb6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2819283effd545c39716b64e8d4a2318_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02. Results of Operations and Financial Condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF83L2ZyYWc6MDk5Zjc4YmZiMWU0NGU2OWE4MDQ4MjVkYTNjZmI4ZDAvdGV4dHJlZ2lvbjowOTlmNzhiZmIxZTQ0ZTY5YTgwNDgyNWRhM2NmYjhkMF82OA_e7701b51-2bbc-44f1-b5be-89a6adcce104">August&#160;3, 2021</ix:nonNumeric>, Pacira BioSciences, Inc. issued a press release announcing its financial results for the second quarter ended June&#160;30, 2021.&#160;The full text of the press release is furnished as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 2.02 and Exhibit&#160;99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-6302021x991.htm">Earnings Press Release dated August 3, 2021.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (Formatted as Inline XBRL)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2819283effd545c39716b64e8d4a2318_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">SIGNATURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACIRA BIOSCIENCES,&#160;INC.<br/>(REGISTRANT)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xMC9mcmFnOmRiMzNiOWRjZmI4NDRiMjU4MTY5ODc4ZWNlNzUwYTExL3RhYmxlOjM0MjdhM2RmN2RlZDQyNWRhNDg2NTVlNDg0ZTVjNDVjL3RhYmxlcmFuZ2U6MzQyN2EzZGY3ZGVkNDI1ZGE0ODY1NWU0ODRlNWM0NWNfMi0xLTEtMS0w_e7701b51-2bbc-44f1-b5be-89a6adcce104">August 3, 2021</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ KRISTEN WILLIAMS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristen Williams</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Administrative Officer and Secretary</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pcrx-6302021x991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0701d700041049efa351ef462615a7c3_1"></div><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><img alt="pacirabiosciencesa01a.jpg" src="pacirabiosciencesa01a.jpg" style="height:70px;margin-bottom:5pt;vertical-align:text-bottom;width:180px"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div style="text-align:right"><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NEWS RELEASE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:103%">-- EXPAREL average daily sales at 178% of the prior year second quarter --</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">-- Conference call today at 8&#58;30 a.m. ET --</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PARSIPPANY, N.J., August&#160;3, 2021 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- Pacira BioSciences, Inc. (Nasdaq&#58; PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the second quarter of 2021.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Second Quarter 2021 Financial Highlights</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Total revenues of $135.6 million</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">GAAP net income of $19.1 million, or $0.43 per share (basic) and $0.42 (diluted)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Non-GAAP Adjusted EBITDA of $50.3 million</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;We made terrific progress in the first half of 2021 with strong sales momentum in the second quarter and continuing in recent weeks,&#8221; said Dave Stack, chairman and chief executive officer of Pacira BioSciences. &#8220;Record revenue in the second quarter significantly ramped our bottom line, allowing us to achieve our highest-ever adjusted EBITDA for a quarter. Market dynamics remain highly favorable and leave us confident that we will deliver robust topline growth, improved margins, and accelerating earnings for the remainder of 2021, leaving us well-positioned to achieve the goals laid out within our five-year plan.&#8221;</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_4"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Second Quarter 2021 Financial Results</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Total revenues were $135.6 million in the second quarter of 2021, versus the $75.5 million reported for the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">EXPAREL net product sales were $130.1 million in the second quarter of 2021, versus the $73.0 million reported for the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Second quarter 2021 iovera&#176; net product sales were $3.8 million, versus the $1.4 million reported for the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Sales of bupivacaine liposome injectable suspension to a third-party licensee for use in veterinary practice were $1.0 million in the second quarter of 2021, versus the $0.8 million in the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Second quarter 2021 royalty and collaborative licensing and milestone revenues were $0.7&#160;million, versus the $0.3 million in the second quarter of 2020.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Total operating expenses were $100.7 million in the second quarter of 2021, compared to $82.7 million in the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Research and development (R&#38;D) expenses were $12.6 million in the second quarter of 2021, compared to $13.6 million in the second quarter of 2020. R&#38;D expenses included $4.6 million and $6.1 million of product development and manufacturing capacity expansion costs in the second quarters of 2021 and 2020, respectively.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Selling, general and administrative (SG&#38;A) expenses were $50.8 million in the second quarter of 2021, compared to $43.3 million in the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">GAAP net income was $19.1 million, or $0.43 per share (basic) and $0.42 (diluted), in the second quarter of 2021, compared to a GAAP net loss of $7.3 million, or $0.17 per share (basic and diluted), in the second quarter of 2020. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Non-GAAP net income was $35.3 million, or $0.80 per share (basic) and $0.77 (diluted), in the second quarter of 2021, compared to non-GAAP net income of $5.0 million, or $0.12 per share (basic and diluted), in the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Adjusted EBITDA was $50.3 million in the second quarter of 2021, compared to $8.5 million in the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Pacira ended the second quarter of 2021 with cash, cash equivalents and short-term investments (&#8220;cash&#8221;) of $646.6 million. Cash provided by operations was $30.1 million in the second quarter of 2021, compared to cash used in operations of $15.6 million in the second quarter of 2020.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Pacira had 44.1 million basic and 45.6 million diluted weighted average shares of common stock outstanding in the second quarter of 2021.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">See &#8220;Non-GAAP Financial Information&#8221; below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recent Business Highlights</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%;padding-left:13.8pt">FDA approval of enhanced EXPAREL manufacturing process. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In July 2021, the U.S. Food and Drug Administration (FDA) approved the company&#8217;s enhanced manufacturing process for EXPAREL, which is housed at a custom facility in Swindon, England under a partnership with Thermo Fisher Scientific Pharma Services. The company expects to start selling commercial product manufactured in this 200-liter suite later this year.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">Patent granted for EXPAREL. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In June 2021, the United States Patent and Trademark Office  issued U.S. Patent No. 11,033,495 related to EXPAREL.  The patent, &#8220;Manufacturing of Bupivacaine Multivesicular Liposomes,&#8221; claims composition of EXPAREL prepared by an improved manufacturing process and will have an expiration date of January 22, 2041. Pacira submitted this patent for listing in the FDA&#8217;s &#8220;Approved Drug Products with Therapeutic Equivalence Evaluations&#8221; (the Orange Book) in July 2021. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">Distribution agreement with Eurofarma in Latin America. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In June 2021, Pacira announced a distribution agreement with Eurofarma Laboratories S.A. (Eurofarma) for the development and commercialization of EXPAREL in Latin America. Under the terms of the agreement, </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Eurofarma obtained the exclusive right to market and distribute EXPAREL in 19 countries including Argentina, Brazil, Colombia, and Mexico.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Guidance</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The company&#8217;s net product sales were negatively impacted by the COVID-19 pandemic in 2020 due to the significant postponement or suspension in the scheduling of elective surgical procedures resulting from public health guidance and government directives. Elective surgery restrictions began to lift on a state-by-state basis in April 2020, allowing EXPAREL sales to return to year-over-year growth in June 2020. However, while many restrictions have since eased and COVID-19 vaccines become more widely available and administered to the general public, it is still unclear how long it will take the elective surgery market to normalize, or if restrictions on elective procedures will recur due to COVID-19 variant strains or otherwise. In order to provide greater transparency, the company is reporting monthly intra-quarter unaudited net product sales until it has gained enough visibility around the impacts of COVID-19. The company reports average daily growth rates for EXPAREL to normalize for differences in the number of selling days per reporting period. The company is also providing weekly EXPAREL utilization and elective surgery data within its investor presentation, which is accessible at investor.pacira.com.</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_7"></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Today&#8217;s Conference Call and Webcast Reminder</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Pacira management team will host a conference call to discuss the company&#8217;s financial results and recent developments today, Tuesday, August&#160;3, 2021, at 8&#58;30 a.m. ET. To participate in the conference call, dial 1-877-845-0779 and provide the passcode 9991311. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the &#8220;Events&#8221; page on the Pacira website at investor.pacira.com.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode 9991311. The replay of the call will be available for one week from the date of the live call. The webcast will be available on the Pacira website for approximately two weeks following the call.</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_10"></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-GAAP Financial Information</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains financial measures that do not comply with U.S. generally accepted accounting principles (GAAP), such as non-GAAP net income, non-GAAP net income per common share, non-GAAP cost of goods sold, non-GAAP research and development (R&#38;D) expense, non-GAAP selling, general and administrative (SG&#38;A) expense and adjusted EBITDA, because these non-GAAP financial measures exclude the impact of items that management believes affect comparability or underlying business trends.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">These measures supplement the company&#8217;s financial results prepared in accordance with GAAP. Pacira management uses these measures to better analyze its financial results, estimate its future cost of goods sold, R&#38;D expense and SG&#38;A expense outlook for 2021 and to help make managerial decisions. In management&#8217;s opinion, these non-GAAP measures are useful to investors and other users of our financial statements by providing greater transparency into the operating performance of Pacira and its future outlook. Such measures should not be deemed to be an alternative to GAAP </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">requirements or a measure of liquidity for Pacira. Non-GAAP measures are also unlikely to be comparable with non-GAAP disclosures released by other companies. See the tables below for a reconciliation of GAAP to non-GAAP measures.</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_13"></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Pacira BioSciences</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc. (Nasdaq&#58; PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients&#8217; journeys along the neural pain pathway. The company&#8217;s long-acting local analgesic, EXPAREL</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera&#176; system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_16"></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About EXPAREL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXPAREL (bupivacaine liposome injectable suspension) is indicated in patients 6 years of age and older for single-dose infiltration to produce postsurgical local analgesia, and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks. The product combines bupivacaine with DepoFoam</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a proven product delivery technology that delivers medication over a desired time period. EXPAREL represents the first and only multivesicular liposome local anesthetic that can be utilized in the peri- or postsurgical setting. By utilizing the DepoFoam platform, a single dose of EXPAREL delivers bupivacaine over time, providing significant reductions in cumulative pain scores with up to a 78 percent decrease in opioid consumption&#59; the clinical benefit of the opioid reduction was not demonstrated. Additional information is available at www.EXPAREL.com.</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_19"></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Important Safety Information for Patients</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXPAREL should not be used in obstetrical paracervical block anesthesia. In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting. In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, and constipation. In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat. EXPAREL can cause a temporary loss of feeling and&#47;or loss of muscle movement. How much and how long the loss of feeling and&#47;or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days. EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and&#47;or in pregnant women. Tell your health care provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body. EXPAREL should not be injected into the spine, joints, or veins. The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system&#59; may cause an allergic reaction&#59; may cause damage if injected into the joints&#59; and can cause a rare blood disorder.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i0701d700041049efa351ef462615a7c3_22"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About iovera&#176;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The iovera&#176; system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. In one study, the majority of the patients suffering from osteoarthritis of the knee experienced pain and system relief beyond 150 days.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The iovera&#176; system&#8217;s &#8220;1&#215;90&#8221; Smart Tip configuration (indicating one needle which is 90 mm long) can also facilitate target nerve location by conducting electrical nerve stimulation from a separate nerve stimulator. The iovera&#176; system is not indicated for treatment of central nervous system tissue.</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Important Safety Information</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The iovera&#176; system is contraindicated for use in patients with the following&#58; Cryoglobulinemia&#59; Paroxysmal cold hemoglobinuria&#59; cold urticaria&#59; Raynaud&#8217;s disease&#59; open and&#47;or infected wounds at or near the treatment line. Potential complications&#58; As with any surgical treatment that uses needle-based therapy, there is potential for temporary site-specific reactions, including but not limited to&#58; bruising (ecchymosis)&#59; swelling (edema)&#59; inflammation and&#47;or redness (erythema)&#59; pain and&#47;or tenderness&#59; altered sensation (localized dysesthesia). Typically, these reactions resolve with no physician intervention. Patients may help the healing process by applying ice packs to the affected sites, and by taking over-the-counter analgesics.</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_25"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Any statements in this press release about the company&#8217;s future expectations, plans, trends, outlook, projections and prospects, and other statements containing the words &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;can&#8221; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to&#58; the impact of the worldwide COVID-19 (Coronavirus) pandemic and related global economic conditions on our business and results of operations&#59; the success of the company&#8217;s sales and manufacturing efforts in support of the commercialization of EXPAREL and iovera&#176;&#59; the rate and degree of market acceptance of EXPAREL and iovera&#176;&#59; the size and growth of the potential markets for EXPAREL and iovera&#176; and the company&#8217;s ability to serve those markets&#59; the company&#8217;s plans to expand the use of EXPAREL and iovera&#176; to additional indications and opportunities, and the timing and success of any related clinical trials for EXPAREL and iovera&#176;&#59; the ability to successfully integrate any future acquisitions into the company&#8217;s existing business and the recoverability of our deferred tax assets and other factors discussed in the &#8220;Risk Factors&#8221; of the company&#8217;s most recent Annual Report on Form 10-K and in other filings that the company periodically makes with the SEC. In addition, the forward-looking statements included in this press release represent the company&#8217;s views as of the date of this press release. Important factors could cause actual results to differ materially from those indicated or implied by forward-looking statements, and as such the company anticipates that subsequent events and developments will cause its views to change. However, while the company may elect to update these forward-looking statements at some point in the future, it</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Radnovich, R. et al. &#8220;Cryoneurolysis to treat the pain and symptoms of knee osteoarthritis&#58; a multicenter, randomized, double-blind, sham-controlled trial.&#8221; Osteoarthritis and Cartilage (2017) p1-10.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the company&#8217;s views as of any date subsequent to the date of this press release.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">###</font></div><div><font><br></font></div><div id="i0701d700041049efa351ef462615a7c3_28"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Susan Mesco, (973) 451-4030</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">susan.mesco&#64;pacira.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Media Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Coyne Public Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Kristin Capone, (973) 588-2108</font></div><div style="text-indent:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">kcapone&#64;coynepr.com</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Tables to Follow)</font></div><div style="text-align:center"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i0701d700041049efa351ef462615a7c3_31"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pacira BioSciences, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br>2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br>2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,774&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,957&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Short-term investments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,821&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,705&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,357&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,046&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,264&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,650&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,265&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,579&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,623&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,459&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,302&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,688&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,492&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,547&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,547&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,588&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,521&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,599&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,164&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment and other assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,966&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325,833&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,274,513&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,179&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,431&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,163&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,974&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,644&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,425&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible senior notes </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,681&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,648&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contingent consideration</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,026&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,736&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,693&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,328&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,708&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,030&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,235&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,025&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,332&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,610&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,697&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,832&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,168&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619,688&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325,833&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,274,513&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Relates to our 2.375% convertible senior notes due 2022. These notes are classified as current at June 30, 2021 and December 31, 2020 because the note holders can convert any time on or after October 1, 2020.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to our 0.750% convertible senior notes due 2025 that are not currently convertible.</font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pacira BioSciences, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Net product sales&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;EXPAREL</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,059&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,046&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,736&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,315&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Bupivacaine liposome injectable suspension</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total EXPAREL &#47; bupivacaine liposome<br>&#160;&#160;&#160;&#160;&#160;&#160;injectable suspension net product sales</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,050&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,821&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,520&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,296&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;iovera&#176;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,081&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,665&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total net product sales</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,863&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,216&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,601&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,961&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Collaborative licensing and milestone revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Royalty revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total revenues</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,590&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,505&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,617&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,189&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of goods sold</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,248&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,305&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,597&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,037&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,573&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,620&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,453&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,440&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Selling, general and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,813&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,342&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,335&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,122&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of acquired intangible assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition-related charges (gains), product <br>&#160;&#160;&#160;&#160;&#160;discontinuation and other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,747&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,652&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,337&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,242&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,843&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,147)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,280&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,947&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,911&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,023)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,456)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,994)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,477)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,396)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,969&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,554)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total other expense, net</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,195)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,909)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,702)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,311)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,371&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax (expense) benefit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,567)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,921)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,269)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per common share</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per common share</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,145&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,221&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,989&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,592&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,221&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,779&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,861&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pacira BioSciences, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Financial Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP net income (loss)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,269)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Milestone revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition-related charges (gains), product<br>&#160;&#160;&#160;&#160;&#160;discontinuation and other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,461&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,222&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,571&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,070&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt discount</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,660&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,401&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,254&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of acquired intangible assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss (gain) on investment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,979)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,585&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,488)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,048)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Non-GAAP adjustments</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,181&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,288&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,336&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,959&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP net income</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,262&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,019&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,786&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,848&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP basic net income (loss) per common share</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP diluted net income (loss) per common share</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP basic net income per common share</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP diluted net income per common share</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,145&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,221&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,989&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,592&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,937&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,779&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,861&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of goods sold reconciliation&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP cost of goods sold</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,248&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,305&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,597&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,037&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,465)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,284)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,917)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,503)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP cost of goods sold</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,783&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,021&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,680&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,534&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and development reconciliation&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP research and development</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,573&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,620&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,453&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,440&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,357)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,435)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,544)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP research and development</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,244&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,263&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,018&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,896&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, general and administrative reconciliation&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP selling, general and administrative</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,813&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,342&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,122&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,667)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,581)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,219)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,023)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP selling, general and administrative</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,146&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,761&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,116&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,099&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:4pt;text-align:center"><font><br></font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pacira BioSciences, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reconciliation of GAAP Net Income (Loss) to Adjusted EBITDA (Non-GAAP)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP net income (loss)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,081&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,269)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,450&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,323)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,911)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,023&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,456&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,994&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,477&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income tax expense (benefit)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,921&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Depreciation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,931&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,023&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,815&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,877&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of acquired intangible assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,933&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,345&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,474&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,621&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related charges (gains), product discontinuation <br>&#160;&#160;&#160;and other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock-based compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,461&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,222&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,571&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,070&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Milestone revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Loss (gain) on investment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,979)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,585&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA (Non-GAAP)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,303&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,524&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,393&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes amortization of debt discount</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) includes GAAP to non-GAAP adjustments that reflect how the Company&#8217;s management analyzes its financial results. The adjusted EBITDA figures presented here are unlikely to be comparable with adjusted EBITDA disclosures released by other companies.</font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pcrx-20210803.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d6d72ee6-cbe1-4374-abb5-192e775bc754,g:2a856f1f-421d-44b5-bcda-7c20170882e4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pcrx="http://www.pacira.com/20210803" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pacira.com/20210803">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20210803_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20210803_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.pacira.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>pcrx-20210803_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d6d72ee6-cbe1-4374-abb5-192e775bc754,g:2a856f1f-421d-44b5-bcda-7c20170882e4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_59a0075f-b4f8-43fb-9b95-c56ee6aa4482_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_13a2be7a-709f-472f-9fe4-3f8c3ff8cf45_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_24fb2fc3-0ee2-4d0b-97fd-fe22ca5f4e52_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b99a21e4-fcd3-4291-a040-fdd940c91547_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b57dbdf7-cf89-4cfe-9589-63edff116be9_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e3fd99b5-5164-4700-ab35-65acc732c899_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_e41a59a6-2d2e-4198-9550-dc0595552533_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_41d5798f-8914-4938-86ec-6cd2f426ae0e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_03629011-ccf0-4095-a6cb-18b551bcae49_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_dac45f35-c1a0-4701-9bf7-fe01a525ebdf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f2f5c62b-4838-4053-892c-b73c7b885423_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_52f9708c-5a4e-44b1-b02a-ed41a5dbb05d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8e187b29-1bee-4c70-b662-0601c3be8fbb_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5cba6f20-31aa-4fef-b0e1-97d7dcd2735e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3bc2a849-a2d3-4321-a0fa-fb4df3bb938e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e53abe5d-502f-4e4e-af23-798431d68ebe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5e2887e4-a7ef-490e-8ffc-732fc679544f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_03a7e61d-9097-4bac-ba5b-504c3621e2dc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6c7390b4-a606-43f3-8e95-a9f85ac4b0b9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4d087ed5-7429-4768-b87d-b983fb3140cb_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fdd59a09-9ce7-40dd-981b-0ee73bf327e9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2d0380bb-ee10-414f-a18c-fc0f1b4dd53f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_14898c8d-24af-4c34-92c3-114ad520f618_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>pcrx-20210803_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d6d72ee6-cbe1-4374-abb5-192e775bc754,g:2a856f1f-421d-44b5-bcda-7c20170882e4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CoverPage" xlink:type="simple" xlink:href="pcrx-20210803.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7e21358d-f158-4f0b-9da4-173737d35464" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_DocumentType_7e21358d-f158-4f0b-9da4-173737d35464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0951ee0d-9d1f-4a90-a15f-a6d9264bb8a4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_DocumentPeriodEndDate_0951ee0d-9d1f-4a90-a15f-a6d9264bb8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b8346e07-0b7b-4c2b-8054-2b79fa546894" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityRegistrantName_b8346e07-0b7b-4c2b-8054-2b79fa546894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b259faa9-66da-425b-9d09-8e5e5e549e8d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b259faa9-66da-425b-9d09-8e5e5e549e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2ac03bc6-af41-4bd6-9700-2d96069f1c20" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityFileNumber_2ac03bc6-af41-4bd6-9700-2d96069f1c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1dfa0447-cf03-43d0-96d2-63a9b5bab58d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityTaxIdentificationNumber_1dfa0447-cf03-43d0-96d2-63a9b5bab58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d553cc37-47da-44a5-8415-377680c9f238" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityAddressAddressLine1_d553cc37-47da-44a5-8415-377680c9f238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3a59a204-53c0-4534-9909-f750f1614370" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityAddressCityOrTown_3a59a204-53c0-4534-9909-f750f1614370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0b058ace-e54c-4217-94b5-7cb0b79d2d92" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityAddressStateOrProvince_0b058ace-e54c-4217-94b5-7cb0b79d2d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9c6cdebe-7d98-4133-b9a6-c4744d69ffce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityAddressPostalZipCode_9c6cdebe-7d98-4133-b9a6-c4744d69ffce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e643504e-55ad-4c00-a247-df0bb0b70d85" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_CityAreaCode_e643504e-55ad-4c00-a247-df0bb0b70d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_969ce27b-0eda-4303-a5eb-f0702b21d061" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_LocalPhoneNumber_969ce27b-0eda-4303-a5eb-f0702b21d061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c07294e7-9c1e-490a-bbc5-6000cfb37b7a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_WrittenCommunications_c07294e7-9c1e-490a-bbc5-6000cfb37b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b9bd5056-999a-4c17-8c6f-151f8dc93729" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_SolicitingMaterial_b9bd5056-999a-4c17-8c6f-151f8dc93729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_2266bdbd-9305-463d-bb5d-08620f2ce879" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_PreCommencementTenderOffer_2266bdbd-9305-463d-bb5d-08620f2ce879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e622e6ea-9370-4586-9215-07ae7ae3a6f0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e622e6ea-9370-4586-9215-07ae7ae3a6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_152c8364-0fe6-4e80-a7b2-7336c6a1a7cb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityEmergingGrowthCompany_152c8364-0fe6-4e80-a7b2-7336c6a1a7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4361e829-4499-4a34-870a-df764672e203" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_Security12bTitle_4361e829-4499-4a34-870a-df764672e203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_38a384f2-b314-4146-93a9-1bd8000dc57b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_TradingSymbol_38a384f2-b314-4146-93a9-1bd8000dc57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_307a8705-f0aa-457f-9561-df4a48148e36" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_SecurityExchangeName_307a8705-f0aa-457f-9561-df4a48148e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f1e0694e-f8ac-4ee5-845b-d252189670af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_EntityCentralIndexKey_f1e0694e-f8ac-4ee5-845b-d252189670af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f7b98f05-1fed-41ea-a022-b1a36d4ac498" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_70e334c0-467a-41e9-8bfc-378fa86f077c" xlink:to="loc_dei_AmendmentFlag_f7b98f05-1fed-41ea-a022-b1a36d4ac498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>pacirabiosciencesa01a.jpg
<DESCRIPTION>PACIRA BIOSCIENCES LOGO
<TEXT>
begin 644 pacirabiosciencesa01a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !     %$2  0    !
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #% ?0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HJ.ZO8;&+S)I8X8QU9V"C\S6%J'Q/TBR)"3-<L.T2Y'YG H Z&BN
M+F^+#3'_ $>S51ZR/G]!_C4(\<:A=_\ +18QZ(@_KFGR@=U2%@O4BN,BU>ZG
M/S7$Q_X$:O6TK.1N9C]32 Z3S%/\2_G3LUDVGW?PK13_ %;4 2YHK,NF(-4+
MB^FB^[+(O_ J .BHKDY/$]Y:MQ(&'HR@TJ_$62!OWUNCCU1MO^-.P'5T5@V?
MQ'TVX($CR6[?[:\?F,UL6>H0:A'OMYHYE]48-2 FHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ^P^&.GV8_>-/.?]IMH_2M6U\-V-G_J[6'\5W?SHYBCD;,9-:UG;R''[M_\
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MN7^1\RLXHK;#P^[_ (!_,GXJ_P""DW[<_@<-<ZWXR^+NCHO+->Z,UO&OUWP
M55\$_P#!?[]K+P3>+(/BI-JT0ZP:EH]A<(_U)A#C\&%?T[$9%> _M7?\$O\
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MMX=OI'@666TEMI(Y4P)(V210=RDX)&5ST)KT:O&O^">/P.A_9N_8;^%?@N*
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MH'_]EK^6FOZL/^"P%I]M_P""8?QO3^[X5NI/^^0&_I7\I]?LGAO+_8:J_O\
MZ(^VX7?^SS7G^B/V\_X-'-/\OX;_ !NNL?Z[4M)BS_N171_]GK]A*_)3_@TJ
MM-G[.OQ;N/\ GIXCM(\_[MMG_P!FK]:Z^!XQE?.*[\U_Z2CY[.W?&U/E^2"O
MB/\ X.)=*;4_^"2/Q*91DVEQI,_T U.U!_\ 0J^W*^0_^"\MI]M_X)*_&-/[
MMC8R?]\ZC:-_2O.R.5LRP[_OP_\ 2D<V7NV*IO\ O+\S^7NOWB_X-,=/\O\
M93^*-UC_ %WBR.+/^Y9Q'_V>OP=K]_?^#4/3_(_8/\=7!'_'QX[N%!]0MA8_
MXFOV'CR5LHFO./YGVG$+_P!B?JOS/U#HHHK\)/S\*AU+3;?6=.N+.\MX;JTN
MHVAG@F021S(P(964\,I!((/!!J:B@#^2_P#X*2?LV6_[(?[='Q,^'M@CQZ5H
M.LNVF(Y+-'93JMQ;*2>6*PRQJ3W()K-_8 ^+UW\!OVW/A3XLLYFA?1_%%@TQ
M4XWV[S+'.GT>%Y%/LQKZ$_X.,+ZWO/\ @K5\1%@96:WL])CFVGH_]FVYY]]I
M6OD[]G?PY<>,/V@? NDVBL]UJGB&PLX54<L\ES&B@?B17](8&H\1E4)U_M4U
M?YQU/T_#R]KA(RJ=8J_S6I_8?1117\WGY@9/C7P-I/Q#T&;3=8LH;ZSF'W7'
MS(?[RMU5AZC!KX[_ &C/V.M6^%JW&K:+YVK^'URS8&ZXLU_VP/O*/[X_$#J?
MMJ@\TU*P6/BO]EW]L^X^&<MOH/BB6:\\/\)!<G+S:=Z#U:,>G51TR!MK[,TO
M5;;7--@O+.XANK6Z020S1.'213R""."#7SM^TW^PQ:^,([C7/!L4-CJQS)-I
MP(2"[/<Q]HW]ONG_ &>2?%/V=?VHM:_9C\4RZ#KUO>R:"LQ2[L95*SZ>^?F>
M,-T/<H>#['FG:^Q.VY]]33);0M)(RQQQ@LS,<*H'4DU_+G^W[\==8_X*M?\
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M5C1%R=N:]HK\BXBS)8_,*F)A\+=EZ)67W[_,^,S/%+$8F56.W3T6@445YO\
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M%OO^44_QH_[ T?\ Z505YV3_ ._T/\<?_2D<N!_WBG_B7YG\M5?T*?\ !JW
M(_\ @G+XB?O)X\OB?PLK 5_/77]#'_!K!_RC=US_ +'J_P#_ $DL:_8./_\
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M@XK[4_X+^_\ !$B$V.L?'CX/:*L+P*UYXQ\/6,.U'4<OJ-O&HX(&3,BC!&9
M 1(6_%JN3(\/DN/H+$X:A"_5.*;3[?Y/J8Y?3P.(IJK2IQ\U9:,^VO!/_!)[
M]L3_ (*":Q8^*M:T/Q+JT&L0)=P>(O&&N!8Y()0'1T,TC2M&RL&'EHPQTK[L
M_9 _X-3_  SX5O;35OC7XVF\4RQ,'?0?#P>TL7_V9+IL3.I_V%B/ ^:O+?\
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M?B)X-TVW6W\/B_\ [4T,1_ZK[!=J+B%8S_$L8D\K/K$:V?\ @CK^V5_PP_\
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M?$\:Y7]3S*4XKW:GO+U>Z^_7T:/"SW">PQ3:VEJOU_$*_EY_X+L?!Z;X,_\
M!4WXK6S1[+7Q!?Q^(+9\<2K>0I,Y'TF:5?JIK^H:OQJ_X.O?V2YK_2_A_P#&
MS3;7>MB&\*:XZKDHC,\]FYQT4,;E"Q[O&.XK?@+'*AF:IRVJ)Q^>Z_*WS+X=
MQ"IXOE?VE;Y[H_%57*,&4E64Y!':O[!?V7_BC%\;OV;/ 'C&&19H_%'AVPU3
M<#GF:W21@?<%B#[@U_'S7]&7_!M'^U%%\<O^">EOX0N;A9-<^%FHRZ1,C-F0
MV<S-<6LA]%^:6)?^O8U]?XC8-U,%3Q"^Q*S])?\ !2^\]KB:BY4(U5]E_G_P
M4C]#J***_&SX@**** "BBB@ HHHH **** /G_P#X*MG'_!-3XZ?]B5J?_I.]
M?R?U_5S_ ,%:I_L__!,WXY-Z^#K]?SB(_K7\HU?L7AO_ +G5_P 7Z(^VX7_@
MS]?T/WE_X-,S_P 8E?$[_L;D_P#2.&OU;K\G?^#3"?=^RY\5(O[GBJ%L?6T0
M?TK]8J^!XN_Y'%?U7Y(^=SK_ 'VIZ_H@KY3_ ."WYQ_P2F^-'_8'B_\ 2J"O
MJRODW_@NA<?9O^"3_P 9F]=+MD_[ZOK8?UKS<G_Y&%#_ !Q_]*1RX'_>*?\
MB7YG\N-?T,?\&L!S_P $WM<_['N__P#2.QK^>>OZ#O\ @U4O/._X)W>*(O\
MGCX\O0?QL; U^P<?_P#(I?\ BC^I]IQ%_N?S1^F3#<,'D'@@]Z_GQ_X. /\
M@C\/V0?'$WQ<^'6F;/ACXHO,:E86T?[OPO?2'A0H^[:RL3L_AC<^7\H,0/\
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M30+ZS6\\.^'[C_A)=;1TW1FULV60(X[K).8(C[2U_4J!@5^3_P#P:I?LJ_\
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MV2_C?X@^'_C73SI_B'PY<F"=02T4ZD;HYHF(&Z*1"KJV!E6' .0/[!J^!/\
M@O#_ ,$IH_V]_@9_PF'A"P1OBQX%M6;3Q&N'UZR!+R6#'J7!+/#G.'++P)2P
M^YX+XD^HUOJN(?[J;_\  7W]'U^_N?09'FGU>?L:C]R7X/\ R[_>?A=_P3N_
M;S\5?\$[_P!I/2?'GAUGN['(M-<TAI-D.LV+,#)"Q_A<8#(^#L=5."-RM_4M
M^SK^T)X5_:I^"_A_Q]X*U)-4\.>([87%M*,!XSDJ\4BY.V2-PR.O\+*17\>\
M\$EK.\4J-')&Q5T8;64C@@CL17W=_P $.?\ @K1=?\$]_C-_PB_BR[N)OA'X
MSND&J)R_]A71 1=0C7DX "K*J\LB@@,T:J?M>,N&?K]+ZUAU^]BO_ EV]5T^
M[M;W,\ROZQ#VU)>^OQ7^?;[C^E"BJ^DZM:Z]I=M?6-S;WEC>1+/;W$$@DBGC
M8!E=&7(92"""#@@YJQ7XB?!A7Y:_\'0_[:X^$?[,FB_!W1[SR]<^)4PN]5$;
M_/!I5NX;![CSIPB@]"L$RGK7ZB7]_!I5C-=74T5O;6T;2S2RN$2)%&69B>
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M^33?Z?J?KYKG[;_P7\,V+7.H?%SX96=N@R7F\3V2#]9*^;_VA_\ @X:_9C^
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MJ\%\UOZ;UC8E<^X&:[JG4ISA+EFFGV>A4HN+M)6"BBFRRK#&SNRJB@LS,<
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M[V>[  &Z::5&DE<X&7=BWO7MFG:?;Z1I\%I:PQ6]K:QK##%$H5(D4855 X
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>pcrx-20210803_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pcrx-20210803.xsd" xlink:type="simple"/>
    <context id="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-08-03</startDate>
            <endDate>2021-08-03</endDate>
        </period>
    </context>
    <dei:DocumentPeriodEndDate
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF80L2ZyYWc6YzE0MjRmMjhhYjdiNGNjYWExOTk1YTk5N2Y1MmU5MDMvdGFibGU6ZWJiNzVhZjJmN2Y5NDA4MGFiZWNiNTIyN2VmNGI4MWYvdGFibGVyYW5nZTplYmI3NWFmMmY3Zjk0MDgwYWJlY2I1MjI3ZWY0YjgxZl8xLTEtMS0xLTA_d1b6273d-63d4-4923-af5e-943691beae87">2021-08-03</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF80L2ZyYWc6YzE0MjRmMjhhYjdiNGNjYWExOTk1YTk5N2Y1MmU5MDMvdGFibGU6ZWJiNzVhZjJmN2Y5NDA4MGFiZWNiNTIyN2VmNGI4MWYvdGFibGVyYW5nZTplYmI3NWFmMmY3Zjk0MDgwYWJlY2I1MjI3ZWY0YjgxZl8yLTEtMS0xLTA_b861c65c-c656-4122-9fbb-85df77b7d293">0001396814</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF80L2ZyYWc6YzE0MjRmMjhhYjdiNGNjYWExOTk1YTk5N2Y1MmU5MDMvdGFibGU6ZWJiNzVhZjJmN2Y5NDA4MGFiZWNiNTIyN2VmNGI4MWYvdGFibGVyYW5nZTplYmI3NWFmMmY3Zjk0MDgwYWJlY2I1MjI3ZWY0YjgxZl8zLTEtMS0xLTA_fdbc3baf-21a8-42d4-a2b5-ecc9f35f1ce0">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ5_6127fe69-b8e2-4844-815c-61c49e1bdf27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8yMjY_e7701b51-2bbc-44f1-b5be-89a6adcce104">2021-08-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQz_f3480471-04dd-40ff-8ccd-44de7488c768">PACIRA BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6NTU3ZmQ3OWMzOTVmNDgwOTg3YjlhMTIzYTQ1MzkxYTgvdGFibGVyYW5nZTo1NTdmZDc5YzM5NWY0ODA5ODdiOWExMjNhNDUzOTFhOF8wLTAtMS0xLTA_f169059c-af58-491b-9e03-56f6ca3b0009">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6NTU3ZmQ3OWMzOTVmNDgwOTg3YjlhMTIzYTQ1MzkxYTgvdGFibGVyYW5nZTo1NTdmZDc5YzM5NWY0ODA5ODdiOWExMjNhNDUzOTFhOF8wLTItMS0xLTA_e8e466c4-ae1f-4ac7-9832-b131d273e8eb">001-35060</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6NTU3ZmQ3OWMzOTVmNDgwOTg3YjlhMTIzYTQ1MzkxYTgvdGFibGVyYW5nZTo1NTdmZDc5YzM5NWY0ODA5ODdiOWExMjNhNDUzOTFhOF8wLTQtMS0xLTA_b1f347b7-9058-4a55-a493-781b6d1846ba">51-0619477</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUw_572a497d-cff7-4f46-8dc1-cb73bc152117">5 Sylvan Way, Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ0_b1a5536e-f3d5-456d-a120-612cf682eb8f">Parsippany</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUx_cdca1949-132f-429f-9983-eb0a0c53fcd5">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ1_116a1fc8-b8eb-4c0a-920c-a96fd8b5687d">07054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ2_d7f891da-8577-4bde-bfe0-6da353c4333a">973</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ3_80e55a02-96ca-42df-971d-433f8237628a">254-3560</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUy_c4325644-8b99-4aec-af29-50f6053aef05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjQ4_069fe899-f4af-41e7-9ade-e638f635d544">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjUz_ff302727-e311-4dec-95b3-cd64b59cf5b0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjU0_c0aedf38-da1a-4033-a6d6-01f2a654e5c9">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6MzNmNzA2Njg0MDk5NGEzM2I5NWI5OTg0NThiMzY3MTcvdGFibGVyYW5nZTozM2Y3MDY2ODQwOTk0YTMzYjk1Yjk5ODQ1OGIzNjcxN18xLTAtMS0xLTA_366fe75b-3f8b-47d2-8c0d-8fb729cd4997">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6MzNmNzA2Njg0MDk5NGEzM2I5NWI5OTg0NThiMzY3MTcvdGFibGVyYW5nZTozM2Y3MDY2ODQwOTk0YTMzYjk1Yjk5ODQ1OGIzNjcxN18xLTItMS0xLTA_f4784542-4378-4015-a78a-2e0098b94ba1">PCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGFibGU6MzNmNzA2Njg0MDk5NGEzM2I5NWI5OTg0NThiMzY3MTcvdGFibGVyYW5nZTozM2Y3MDY2ODQwOTk0YTMzYjk1Yjk5ODQ1OGIzNjcxN18xLTQtMS0xLTA_3bc69477-7782-439a-8c06-6ebd951427bf">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xL2ZyYWc6M2Q5NTEzNjkwMDdjNDVlYTliMGVmZGMyMzkyNmI2NGUvdGV4dHJlZ2lvbjozZDk1MTM2OTAwN2M0NWVhOWIwZWZkYzIzOTI2YjY0ZV8xNjU1_a01f5c6c-7310-4d32-ad86-783c0bdf4bb6">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentPeriodEndDate
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF83L2ZyYWc6MDk5Zjc4YmZiMWU0NGU2OWE4MDQ4MjVkYTNjZmI4ZDAvdGV4dHJlZ2lvbjowOTlmNzhiZmIxZTQ0ZTY5YTgwNDgyNWRhM2NmYjhkMF82OA_e7701b51-2bbc-44f1-b5be-89a6adcce104">2021-08-03</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOjI4MTkyODNlZmZkNTQ1YzM5NzE2YjY0ZThkNGEyMzE4L3NlYzoyODE5MjgzZWZmZDU0NWMzOTcxNmI2NGU4ZDRhMjMxOF8xMC9mcmFnOmRiMzNiOWRjZmI4NDRiMjU4MTY5ODc4ZWNlNzUwYTExL3RhYmxlOjM0MjdhM2RmN2RlZDQyNWRhNDg2NTVlNDg0ZTVjNDVjL3RhYmxlcmFuZ2U6MzQyN2EzZGY3ZGVkNDI1ZGE0ODY1NWU0ODRlNWM0NWNfMi0xLTEtMS0w_e7701b51-2bbc-44f1-b5be-89a6adcce104">2021-08-03</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140418279001832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  03,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PACIRA BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0619477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Sylvan Way, Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Parsippany<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">254-3560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PCRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $U  U,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !-0 -339VR^^T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TU!)71S43PI""XHWD(RNQMLTI",M/OVMG&WB^@#>,S,GV^^
M@>E,E&9(^)R&B(D<YJO)]R%+$S?L0!0E0#8']#K7<R+,S=V0O*;YF?80M?G0
M>P3!^35X)&TU:5B 55R)3'762)-0TY!.>&M6?/Q,?8%9 ]BCQT 9FKH!II:)
M\3CU'5P "XPP^?Q=0+L22_5/;.D .R6G[-;4.([UV);<O$,#;T^/+V7=RH5,
M.AB<?V4GZ1AQP\Z37]N[^^T#4X*+IN*W%6^WC9!<2''SOKC^\+L(^\&ZG?O'
MQF=!U<&ONU!?4$L#!!0    ( $U  U.97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M!I1?_,'95A_=$]N5I93/MC%/;CJN)6(IBXV5H'!Y80%+4ZL$'/\>1#O5;]K
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M='@//GL?)=-[*CG_5U/\!%!+ P04    " !-0 -3EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( $U  U,9117U-P$
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M'R:/6D;KW$JY]_!*MAQSCG^T_ %02P,$%     @ 34 #4R0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( $U  U-ED'F2&0$
M ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@
MIAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1
M?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI
M>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UP
MZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T
M,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^
MD<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#
M%     @ 34 #4P=!36*!    L0   !               ( !     &1O8U!R
M;W!S+V%P<"YX;6Q02P$"% ,4    " !-0 -339VR^^T    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !-0 -3
MF5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( $U  U.)-YP1/00  #X0   8              "
M@0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !-0 -3
MGZ ;\+$"  #B#   #0              @ %_#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( $U  U.7BKL<P    !,"   +              "  5L/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( $U  U,9117U-P$  "<"   /
M      "  400  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !-0 -3)!Z;
MHJT   #X 0  &@              @ &H$0  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !-0 -399!YDAD!  #/ P  $P
M    @ &-$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #7
%$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pcrx-20210803.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="pcrx-20210803.htm">pcrx-20210803.htm</File>
    <File>pcrx-20210803.xsd</File>
    <File>pcrx-20210803_lab.xml</File>
    <File>pcrx-20210803_pre.xml</File>
    <File>pcrx-6302021x991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pcrx-20210803.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "pcrx-20210803.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pcrx-20210803_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pcrx-20210803_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pcrx-20210803.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "pcrx",
   "nsuri": "http://www.pacira.com/20210803",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210803.htm",
      "contextRef": "i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.pacira.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210803.htm",
      "contextRef": "i9d28d6e69cf643439b34fc480b7218de_D20210803-20210803",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001396814-21-000048-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001396814-21-000048-xbrl.zip
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M^FG =R9N/,=BP9(I*9\J^9>?*OG03L06.Y^8?X:2=!'PSR7F)Y. +JIA%'(
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M';F#_(%(24F;\G3>/JRCM$[8U[';,W^X:+OO%\OH!+L-7XU^ U!+ P04
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MWFT[3L_&YC2=IU%$#FA#6=$SHAVUV__$;2FK8-OM*;O31CY^L?[O/$D5FJO
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M[FX_,M<O^A/N0KY>O-&B_F[Q3+PSV'"T=[>C?6L?BS_:^R]02P,$%     @
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MRA2(-/DQRM(@BKY+/CM),X:I#'@P@AE_Y_FT8YR"SSV!MG<B%8?I>B:[$XT
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M&9)(=@*"%R8"%53EGI6&.2Q9ZG 3/.A,@\2>E)JYJWFVF4$R!FMCB"L<P+M
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MLRGXWIQS\<S4#-.B=M/6:D;EH60URUHE6LW8(?]X_/,N2K& ^_F,)-^WC:)
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MW@%MO3]JO3NT7?H /ZW\'PV 6RZUS*KJ_AJ^.^GBW32T>^9D 6RV.K33K"J
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M$PHKF^G@A=GU<TNO*6OO D^N4#LC3T%,(Q+FYM]L30M)!RPE,>\%W$O)('J
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M>"TR,#(Q,#@P,RYX<V102P$"% ,4    " !-0 -3XJC(^(,*  !$7@  %0
M            @ $-&   <&-R>"TR,#(Q,#@P,U]L86(N>&UL4$L! A0#%
M  @ 34 #4T[CBSBI!@  Y#   !4              ( !PR(  '!C<G@M,C R
M,3 X,#-?<')E+GAM;%!+ 0(4 Q0    ( $U  U-X7G8U+#L  -7# P 4
M          "  9\I  !P8W)X+38S,#(P,C%X.3DQ+FAT;5!+!08     !0 %
+ $8!  #]9      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
